Literature DB >> 11743484

Evaluation of a waterless, scrubless chlorhexidine gluconate/ethanol surgical scrub for antimicrobial efficacy.

G Mulberrry1, A T Snyder, J Heilman, J Pyrek, J Stahl.   

Abstract

A new waterless surgical hand preparation containing 1% chlorhexidine gluconate (CHG) and 61% ethyl alcohol was evaluated for antimicrobial efficacy in comparison with a standard 4% CHG surgical scrub and a 61% ethyl alcohol control. Clinical studies were based on the Tentative Final Monograph for Health-Care Antiseptic Drug Products (TFM) (proposed rule) and the Standard Test Method for Evaluation of Surgical Hand Scrub Formulations (ASTM E1115-91). Two randomized, blinded, well-controlled clinical studies involving 137 healthy subjects were conducted to evaluate the antimicrobial effectiveness of the CHG/ethanol hand preparation in producing an immediate and persistent reduction in the normal bacterial flora of the hands. The CHG/ethanol hand preparation was applied without scrubbing or the use of water, and a standard 4% CHG reference product was applied with a scrub brush in 2 traditional 3-minute surgical scrubs. In 1 study, a 61% ethanol vehicle control treatment was applied without scrubbing or use of water. During a 5-day period, each study subject performed a series of 11 surgical scrubs with 1 of the test treatments. After the first treatment on days 1, 2, and 5, surgical gloves were worn for 3 or 6 hours. Bacterial samples were taken with the glove-juice technique at 1 minute, 3 hours, and 6 hours after treatment. The immediate bactericidal effect of the CHG/ethanol hand preparation after a single application resulted in a 2.5-log reduction in normal flora. This bactericidal effect persisted throughout the studies and eventually increased to a 3.6-log reduction after the 11th scrub on day 5. The log reductions of the CHG/ethanol hand preparation proved to be significantly better (P <.05) than that of the 4% CHG product at each sampling interval on days 1 and 2 and the sampling at 6 hours on day 5 and significantly better than the 61% ethanol vehicle at all times. The combination of 1% CHG and 61% ethanol had significantly greater microbial reduction than either the 4% CHG (without ethanol) or the 61% ethanol vehicle (without CHG).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743484     DOI: 10.1067/mic.2001.118842

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Evaluation of two methods of determining the efficacies of two alcohol-based hand rubs for surgical hand antisepsis.

Authors:  Günter Kampf; Christiane Ostermeyer; Peter Heeg; Daryl Paulson
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Comparison of the efficacy of chlorhexidine gluconate versus povidone iodine as preoperative skin preparation for the prevention of surgical site infections in clean-contaminated upper abdominal surgeries.

Authors:  Anirudh Srinivas; Lileswar Kaman; Prithivi Raj; Vikas Gautam; Divya Dahiya; Gurpreet Singh; Rajinder Singh; Bikash Medhi
Journal:  Surg Today       Date:  2014-11-09       Impact factor: 2.549

Review 3.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

4.  Efficacy of two distinct ethanol-based hand rubs for surgical hand disinfection -- a controlled trial according to prEN 12791.

Authors:  Günter Kampf; Christiane Ostermeyer
Journal:  BMC Infect Dis       Date:  2005-03-22       Impact factor: 3.090

5.  Small volumes of n-propanol (60%) applied for 3 minutes may be ineffective for surgical hand disinfection.

Authors:  Günter Kampf; Christiane Ostermeyer
Journal:  Antimicrob Resist Infect Control       Date:  2014-04-24       Impact factor: 4.887

Review 6.  Surgical hand antisepsis to reduce surgical site infection.

Authors:  Judith Tanner; Jo C Dumville; Gill Norman; Mathew Fortnam
Journal:  Cochrane Database Syst Rev       Date:  2016-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.